95 related articles for article (PubMed ID: 11071704)
1. Effect of chronic olanzapine treatment on striatal synaptic organization.
Roberts RC
Synapse; 2001 Jan; 39(1):8-15. PubMed ID: 11071704
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum.
Roberts RC; Gaither LA; Gao XM; Kashyap SM; Tamminga CA
Synapse; 1995 Jul; 20(3):234-43. PubMed ID: 7570355
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rats: a study of unlabeled and enkephalin-labeled striatal terminals.
Roberts RC; Lapidus B
J Neural Transm (Vienna); 2003 Sep; 110(9):961-75. PubMed ID: 12938022
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic synapses in the matrix of the ventrolateral striatum after chronic haloperidol treatment.
Roberts RC; Force M; Kung L
Synapse; 2002 Aug; 45(2):78-85. PubMed ID: 12112400
[TBL] [Abstract][Full Text] [Related]
5. Effects of haloperidol on cholinergic striatal interneurons: relationship to oral dyskinesias.
Kelley JJ; Roberts RC
J Neural Transm (Vienna); 2004 Aug; 111(8):1075-91. PubMed ID: 15254795
[TBL] [Abstract][Full Text] [Related]
6. Correlation of vacuous chewing movements with morphological changes in rats following 1-year treatment with haloperidol.
Meshul CK; Andreassen OA; Allen C; Jørgensen HA
Psychopharmacology (Berl); 1996 Jun; 125(3):238-47. PubMed ID: 8815959
[TBL] [Abstract][Full Text] [Related]
7. Haloperidol-induced dyskinesia is associated with striatal NO synthase suppression: reversal with olanzapine.
Nel A; Harvey BH
Behav Pharmacol; 2003 May; 14(3):251-5. PubMed ID: 12799528
[TBL] [Abstract][Full Text] [Related]
8. Chronic olanzapine or sertindole treatment results in reduced oral chewing movements in rats compared to haloperidol.
Gao XM; Sakai K; Tamminga CA
Neuropsychopharmacology; 1998 Nov; 19(5):428-33. PubMed ID: 9778664
[TBL] [Abstract][Full Text] [Related]
9. Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways.
Sakai K; Gao XM; Hashimoto T; Tamminga CA
Synapse; 2001 Feb; 39(2):152-60. PubMed ID: 11180502
[TBL] [Abstract][Full Text] [Related]
10. Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to "early onset" vacuous chewing.
Marchese G; Casu MA; Bartholini F; Ruiu S; Saba P; Gessa GL; Pani L
Eur J Neurosci; 2002 Apr; 15(7):1187-96. PubMed ID: 11982629
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of antipsychotics on haloperidol-induced vacuous chewing movements and subcortical gene expression in the rat.
McCullumsmith RE; Stincic TL; Agrawal SM; Meador-Woodruff JH
Eur J Pharmacol; 2003 Sep; 477(2):101-12. PubMed ID: 14519413
[TBL] [Abstract][Full Text] [Related]
12. Oral dyskinesias and morphological changes in rat striatum during long-term haloperidol administration.
Andreassen OA; Meshul CK; Moore C; Jørgensen HA
Psychopharmacology (Berl); 2001 Aug; 157(1):11-9. PubMed ID: 11512038
[TBL] [Abstract][Full Text] [Related]
13. Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias.
Meredith GE; De Souza IE; Hyde TM; Tipper G; Wong ML; Egan MF
J Neurosci; 2000 Oct; 20(20):7798-806. PubMed ID: 11027244
[TBL] [Abstract][Full Text] [Related]
14. Acute administration of antipsychotics modulates Homer striatal gene expression differentially.
de Bartolomeis A; Aloj L; Ambesi-Impiombato A; Bravi D; Caracò C; Muscettola G; Barone P
Brain Res Mol Brain Res; 2002 Jan; 98(1-2):124-9. PubMed ID: 11834303
[TBL] [Abstract][Full Text] [Related]
15. The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats.
Turrone P; Remington G; Kapur S; Nobrega JN
Psychopharmacology (Berl); 2003 Jan; 165(2):166-71. PubMed ID: 12417967
[TBL] [Abstract][Full Text] [Related]
16. Haloperidol reverses the changes in striatal glutamatergic immunolabeling following a 6-OHDA lesion.
Meshul CK; Allen C
Synapse; 2000 May; 36(2):129-42. PubMed ID: 10767060
[TBL] [Abstract][Full Text] [Related]
17. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
[TBL] [Abstract][Full Text] [Related]
18. Failure to down regulate NMDA receptors in the striatum and nucleus accumbens associated with neuroleptic-induced dyskinesia.
Hamid EH; Hyde TM; Baca SM; Egan MF
Brain Res; 1998 Jun; 796(1-2):291-5. PubMed ID: 9689480
[TBL] [Abstract][Full Text] [Related]
19. Chronic administration of haloperidol and olanzapine attenuates ketamine-induced brain metabolic activation.
Duncan GE; Miyamoto S; Lieberman JA
J Pharmacol Exp Ther; 2003 Jun; 305(3):999-1005. PubMed ID: 12626664
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of treatment with typical and atypical antipsychotic drugs on adenylyl cyclase and G proteins.
Kaplan GB; Leite-Morris KA; Keith DJ
Neurosci Lett; 1999 Oct; 273(3):147-50. PubMed ID: 10515180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
